Johan Langendoen ▲ Sign in to save

• Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study

  2026 Thrombosis Research article Medicine Palliative Care and End-of-Life Issues Open access

  2

  citations
• Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study

  2025 Thrombosis Update article Medicine Palliative Care and End-of-Life Issues Open access

  2

  citations
• Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi studyFor the DELPHI Serenity Group

  2025 SSRN Electronic Journal preprint Medicine Palliative Care and End-of-Life Issues Open access

  0

  citations
• 066 Optimising antithrombotic therapy for people with cancer at the end-of-life: protocol for developing, evaluating and implementing the ‘serenity’ shared decision support tool

  2024 conference-abstract Medicine Palliative Care and End-of-Life Issues

  2

  citations
• 068 Patient and public involvement in a pan-European study to develop and evaluate a shared decision-making support tool to support decisions about antithrombotic therapy in patients with advanced cancer towards the end of life

  2024 conference-abstract Health Professions Mental Health and Patient Involvement

  1

  citations
• Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool

  2023 Thrombosis Research article Medicine Palliative Care and End-of-Life Issues Open access

  25

  citations

6 results